RATIONALE: Sleep studies are laborious, expensive, inaccessible, and inconvenient for diagnosing obstructive sleep apnea (OSA) in children. OBJECTIVES: To examine whether the urinary proteome uncovers specific clusters that are differentially expressed in the urine of children with OSA. METHODS: Two-dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry proteomics followed by validation with western blot of ELISA. MEASUREMENTS AND MAIN RESULTS: Morning urine proteins from 60 children with polysomnographically confirmed OSA and from matched children with primary snoring (n = 30) and control subjects (n = 30) were assessed. A total of 16 proteins that are differentially expressed in OSA were identified, and 7 were confirmed by either immunoblots or ELISA. Among the latter, receiver-operator curve analyses of urinary concentrations of uromodulin, urocortin-3, orosomucoid-1, and kallikrein assigned favorable predictive properties to these proteins. Furthermore, combinatorial approaches indicated that the presence of values beyond the calculated cutoff concentrations for three or more of the proteins yielded a sensitivity of 95% and a specificity of 100%. CONCLUSIONS: Proteomic approaches reveal that pediatric OSA is associated with specific and consistent alterations in urinary concentrations of specific protein clusters. Future studies aiming to validate this approach as a screening method of habitually snoring children appears warranted.
RATIONALE: Sleep studies are laborious, expensive, inaccessible, and inconvenient for diagnosing obstructive sleep apnea (OSA) in children. OBJECTIVES: To examine whether the urinary proteome uncovers specific clusters that are differentially expressed in the urine of children with OSA. METHODS: Two-dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry proteomics followed by validation with western blot of ELISA. MEASUREMENTS AND MAIN RESULTS: Morning urine proteins from 60 children with polysomnographically confirmed OSA and from matched children with primary snoring (n = 30) and control subjects (n = 30) were assessed. A total of 16 proteins that are differentially expressed in OSA were identified, and 7 were confirmed by either immunoblots or ELISA. Among the latter, receiver-operator curve analyses of urinary concentrations of uromodulin, urocortin-3, orosomucoid-1, and kallikrein assigned favorable predictive properties to these proteins. Furthermore, combinatorial approaches indicated that the presence of values beyond the calculated cutoff concentrations for three or more of the proteins yielded a sensitivity of 95% and a specificity of 100%. CONCLUSIONS: Proteomic approaches reveal that pediatric OSA is associated with specific and consistent alterations in urinary concentrations of specific protein clusters. Future studies aiming to validate this approach as a screening method of habitually snoring children appears warranted.
Authors: Visith Thongboonkerd; Evelyne Gozal; Leroy R Sachleben; John M Arthur; William M Pierce; Jian Cai; Julie Chao; Michael Bader; Joao B Pesquero; David Gozal; Jon B Klein Journal: J Biol Chem Date: 2002-07-16 Impact factor: 5.157
Authors: Raouf Amin; Virend K Somers; Keith McConnell; Paul Willging; Charles Myer; Marc Sherman; Gary McPhail; Ashley Morgenthal; Matthew Fenchel; Judy Bean; Thomas Kimball; Stephen Daniels Journal: Hypertension Date: 2007-12-10 Impact factor: 10.190
Authors: Lena Lavie; Holger Kraiczi; Aya Hefetz; Haifa Ghandour; Ana Perelman; Jan Hedner; Peretz Lavie Journal: Am J Respir Crit Care Med Date: 2002-06-15 Impact factor: 21.405
Authors: David Gozal; Leila Kheirandish-Gozal; Laura D Serpero; Oscar Sans Capdevila; Ehab Dayyat Journal: Circulation Date: 2007-10-29 Impact factor: 29.690
Authors: Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal Journal: Sleep Med Rev Date: 2014-11-28 Impact factor: 11.609
Authors: Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper Journal: J Proteome Res Date: 2012-10-26 Impact factor: 4.466
Authors: Janet M Mullington; Sabra M Abbott; Judith E Carroll; Christopher J Davis; Derk-Jan Dijk; David F Dinges; Philip R Gehrman; Geoffrey S Ginsburg; David Gozal; Monika Haack; Diane C Lim; Madalina Macrea; Allan I Pack; David T Plante; Jennifer A Teske; Phyllis C Zee Journal: Sleep Date: 2016-04-01 Impact factor: 5.849
Authors: Ibrahim Elsharkawi; David Gozal; Eric A Macklin; Lauren Voelz; Gil Weintraub; Brian G Skotko Journal: Sleep Med Date: 2017-03-07 Impact factor: 3.492